In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance

Journal of Veterinary Diagnostic Investigation

Volumn 8, Issue 3, 1996, Pages 332-336

  Salmon, Sarah A ^a   Watts, Jeffrey L ^a   Yancey Jr , Robert J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; DESFUROYLCEFTIOFUR;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; CATTLE; DRUG EFFECT; ESCHERICHIA COLI; HAEMOPHILUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PASTEURELLA; SALMONELLA; STAPHYLOCOCCUS; STREPTOCOCCUS;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; BACTERIAL INFECTIONS; CATTLE; CEPHALOSPORINS; ESCHERICHIA COLI; HAEMOPHILUS; MICROBIAL SENSITIVITY TESTS; PASTEURELLA; SALMONELLA; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0030178698     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063879600800309     Document Type: Article

References (20)

1. Amsterdam D: 1991, Susceptibility testing of antimicrobial agents in liquid media. In: Antibiotics in laboratory medicine, ed. Lorian V, 3rd ed., pp. 53-105. Williams and Wilkins, Baltimore, MD.
2. Brown SA, Jaglan PS, Banting A: 1991, Ceftiofur sodium: disposition, protein-binding, metabolism, and residue profile in various species. Acta Vet Scand Suppl 87:97-99.
3. Brown SA, Yancey RJ Jr, Steffan J: 1991, Ceftiofur sodium: antimicrobial activity of parent ceftiofur and metabolites. Acta Vet Scand Suppl 87:95-97.
4. Cabana BE, Van Harken DR, Hottendorf GH: 1976, Comparative pharmacokinetics and metabolism of cephapirin in laboratory animals and humans. Antimicrob Agents Chemother 10:307-317.
5. Chamberlain J, Coombes JD, Dell D, et al.: 1980, Metabolism of cefotaxime in animals and man. J Antimicrob Chemother Suppl 6:69-78.
6. Halstead SL, Walker RD, Baker JC, et al.: 1992, Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretion from healthy beef-bred calves. Can J Vet Res 56:269-274.
7. Jaglan PS, Cox BL, Arnold TS, et al.: 1990, Liquid chromatographic determination of desfuroylceftiofur metabolite of ceftiofur as residue in cattle plasma. J Assoc Of Anal Chem 73: 26-30.
8. Jaglan PS, Kubicek MF, Arnold TS, Cox BL, et al.: 1989, Metabolism of ceftiofur. Nature of urinary and plasma metabolites in rats and cattle. J Agric Food Chem 37:1112-1118.
9. Jaglan PS, Roof RD, Vein FS, et al.: 1994, Concentration of ceftiofur metabolites in plasma and lung of horses following intramuscular treatment. J Vet Pharmacol Ther 17:24-30.
10. Jaglan PS, Vein FS, Hornish RE, et al.: 1992, Depletion of intramuscularly injected ceftiofur from the milk of dairy cattle. J Dairy Sci 75:1870-1876.
11. Jones RN: 1989, A review of cephalosporin metobolism: a lesson to be learned for future chemotherapy. Diagn Microbiol Infect Dis 12:25-31.
12. Jones RN, Barry AL, Thornsberry C: 1982, Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy. Rev Infect Dis Suppl 4:366-373.
13. Jones RN, Packer RR: 1984, Cefotaxime, cephalothin, and cephapirin: antimicrobial activity and synergy studies of cephalosporins with significant in vivo desacetyl metabolite concentrations. Diagn Microbiol Infect Dis 2:65-68.
14. Lee CC, Herr EB Jr, Anderson RC: 1963, Pharmacological and toxicololgical studies on cephalothin. Clin Med 70:1123-1138.
15. National Committee for Clinical Laboratory Standards: 1990, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed., Approved standard M7-A2. NCCLS, Villanova, PA.
16. National Committee for Clinical Laboratory Standards: 1994, Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: proposed standard M31-P. NCCLS, Villanova, PA.
17. Piédrola G, Galan I, Leyva A, Maroto MC: 1988, Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates. Drugs Suppl 35:62-64.
18. Wick WE: 1965, In vitro and in vivo laboratory comparison of cephalothin and desacetylcepahlothin. Antimicrob Agents Chemother 5:870-875.
19. Wise R, Wills PJ, Andrews JM, Bedford KA: 1980, Activity of cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins. Antimicrob Agents Chemother 17:84-86.
20. Yancey RJ Jr, Kinney ML, Roberts BJ, et al.: 1987, Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice. Am J Vet Res 7:1050-1053.